Wendell Wierenga - 22 Dec 2025 Form 4 Insider Report for CYTOKINETICS INC (CYTK)

Role
Director
Signature
/s/ John O. Faurescu, attorney-in-fact for Dr. Wierenga
Issuer symbol
CYTK
Transactions as of
22 Dec 2025
Net transactions value
-$1,170,600
Form type
4
Filing time
23 Dec 2025, 16:13:49 UTC
Previous filing
27 Oct 2025
Next filing
06 Jan 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
WIERENGA WENDELL Director 350 OYSTER POINT BLVD, SOUTH SAN FRANCISCO /s/ John O. Faurescu, attorney-in-fact for Dr. Wierenga 23 Dec 2025 0001239956

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYTK Common Stock Options Exercise $152,200 +20,000 +62% $7.61 52,444 22 Dec 2025 Direct
transaction CYTK Common Stock Sale $1,322,800 -20,000 -38% $66.14 32,444 22 Dec 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYTK Non-Qualified Stock Option (Right to Buy) Options Exercise $0 -20,000 -100% $0.000000 0 22 Dec 2025 Common Stock 20,000 $7.61 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).